
|Articles|January 15, 2003
Improved form of brimonidine has fewer contraindications
Brimonidine tartrate 0.15% (Alphagan P, Allergan) is a "new and improved" version of brimonidine 0.2% (Alphagan, Allergan). It continues to have an efficacy profile similar to the one ophthalmologists have grown used to with brimonidine 0.2%.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
AAO 2025: Glaucoma laser surgery with Joel S. Schuman, MD, FACS
3
News from Orlando: AAO 2025 highlights research across all areas of eyecare
4
AAO 2025: Clinical outcomes of early vs delayed pegcetacoplan treatment in GA
5